Ledger. Australian venture funding, tracked

CEO, Prota Therapeutics

Professor Mimi Tang

Coverage

Stories naming Professor Mimi Tang. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

4 deals

Four Aussie startups that have raised $94.5 million already in January

Roundup of January 2024 funding: Futurerent, Prota Therapeutics, National Renewable Network and Getmee together secured $94.5 million across debt, equity and a government grant, with investor details for each deal.

Series A $32m

Allergies biotech startup Prota Therapeutics innoculated with $32 million in Series A1 raise

Prota Therapeutics, a Melbourne biotech, has secured $32 million in equity and debt ahead of a Phase 3 trial of its peanut allergy therapy, with Singapore's SPRIM Global Investments leading the round.

Also SmartCompany·SmartCompany·SmartCompany·Business News Australia·Forbes Australia

Something wrong? Tell us